The Greater Cannabis Company, Inc. (GCAN) 是一家上市公司 属于 医疗保健 板块，经营于 制药 - 专科与仿制药 行业. 公司总部位于 Baltimore, MD, 美国. 现任CEO为 Aitan Zacharin.
GCAN 拥有 IPO日期为 2018-09-18, 1 名全职员工, 在 Other OTC, 市值为 $188.15K.
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.
